top of page

Navigating the EU MDR Labelling Requirements: A Comprehensive Guide


Navigating the EU MDR Labelling Requirements: A Comprehensive Guide

The European Union Medical Device Regulation (EU MDR) has ushered in a new era of regulatory compliance for medical device manufacturers. Among the many changes brought about by EU MDR, labeling requirements have undergone significant revisions. These requirements have a direct impact on how medical devices are labeled, packaged, and presented to the market. In this blog post, we'll delve into the intricacies of EU MDR labelling to help you understand and comply with these essential regulations.


EU MDR (Regulation (EU) 2017/745) is a comprehensive regulatory framework designed to ensure the safety and performance of medical devices within the European Union. Its primary objective is to enhance patient safety by enforcing rigorous standards for the development, manufacturing, and marketing of medical devices.


The Significance of Labeling


Labeling plays a crucial role in ensuring that medical devices are used safely and effectively. It provides critical information to healthcare professionals, patients, and regulatory authorities. Effective labeling is essential for minimizing risks and errors associated with device use. Components of Medical Device Labeling include the label itself, Instructions for Use or Patient Information, information intended for the patient, and other details such as technical descriptions.


Key Changes in EU MDR Labeling


EU MDR brings several key changes to the labeling requirements for medical devices:


  • UDI (Unique Device Identification): EU MDR mandates the use of a Unique Device Identifier (UDI) for most medical devices. UDI is a combination of numeric or alphanumeric characters that uniquely identifies a specific device. It must be included on the label and, in some cases, on the product itself.

  • Language Requirements: Labels must be in the official language(s) of the Member State where the device is intended to be marketed. Additionally, the label and instructions for use should be available in a clear and understandable language.

  • Symbols: The use of standardized symbols is encouraged to convey essential information, provided they are accompanied by a clear explanation.

  • Changes to Symbols: Some symbols have been updated or modified, and manufacturers must ensure they use the correct symbols as per EU MDR guidance.

  • Addressing Specific End Users: The label should be designed to cater to the needs of specific end users, such as healthcare professionals and patients. This may include clear instructions, safety information, and precautions.

Labeling Considerations for Different Device Classes


The labeling requirements can vary depending on the risk classification of the medical device. Manufacturers should familiarize themselves with the classification rules outlined in Annex VIII of EU MDR to determine their device's risk class and associated labeling requirements.

If the product is a special or customized device, its status must be clearly indicated on the label. For example, if it is intended solely for clinical investigation, this purpose should be explicitly stated.


For devices containing absorbent materials or those that may disperse locally in the human body, the labeling should provide information about the material's composition and quantitative details of its key constituents.


Explicit labeling is also necessary for single-use and sterile devices. Reprocessed devices should indicate the number of times they can be reprocessed, the number of times they have undergone reprocessing, and the sterilization method used.


Labels must declare the presence of CMR (carcinogenic, mutagenic, toxic for reproduction) substances and endocrine-disrupting substances if their concentration exceeds 0.1% w/w. A list of such substances should be included on the device and/or packaging.


Furthermore, labels must indicate the presence of blood and tissue derivatives, even when contained in the medicinal substance of combination devices.


Labeling Documentation and Traceability


EU MDR places an increased emphasis on documentation and traceability of labeling. Manufacturers are required to maintain comprehensive records of the label's content, translations, and any changes made during the product lifecycle.


Clinical Data and Labeling


Clinical data plays a pivotal role in labeling, especially for high-risk devices. Manufacturers must ensure that the labeling reflects the most up-to-date clinical data, and any changes to the labeling due to new clinical information must be promptly implemented.


Transitioning to EU MDR Labeling


If you are a manufacturer already marketing devices in the EU, it is imperative to transition your labeling to comply with EU MDR. This involves a comprehensive review of your labeling materials, including instructions for use, symbols, and UDI implementation. The key points regarding medical device labeling requirements:

  • Medical Device Symbol: Manufacturers must include the medical device symbol on the device and all levels of packaging to indicate that the product is a medical device. The label should also display the trade name and the device's original name.

  • UDI (Unique Device Identification): Regulations detailed in Article 27, 28, 29, and Annex VI (A, B, C) specify rules for UDI. The label must now incorporate a UDI carrier, which includes both an Automated Identification for Data Capture (AIDC) and a Human-Readable Interpretation (HRI) representation of the UDI. Higher packaging levels of the device should also have their own UDI carrier.

  • Electronic Information for Use (eIFU): Medical device labeling may include a web address (URL) for electronic Information for Use (eIFUs), in addition to paper IFUs. eIFUs are particularly useful for implantable devices, active implantable devices, fixed medical devices, and software intended for laymen.

  • Information of Economic Operators (EOs): While the manufacturer's information is typically on the label, foreign manufacturers should include the authorized representative's details on commercial labels.

  • Warnings and Precautions: The label must contain warnings and precautions. While the information can be concise, more details can be provided in the IFU.

  • Country-Specific Labeling Requirements: Manufacturers must adhere to the labeling requirements of specific EU Member States, which may vary in terms of language. Non-compliance can be costly and may lead to recalls and Corrective and Preventive Action (CAPA).

  • Prohibited Acts (Article 7): Manufacturers must not mislead users or patients about the device's intended purpose, safety, or performance. This includes not attributing functions or properties to the device that it does not possess and informing users of likely risks.

  • Economic Operators (Articles 13, 16): Labels should indicate the company name and address. Distributors or importers who modify devices must indicate their activities along with their names, trade names, trademarks, and addresses.

  • Labeling and IFU Accompanying the Device (Articles 18, 21): Instructions for use (IFUs) must be provided with the device. IFUs should cover cleaning and disinfection procedures, packaging, sterilization methods, reuse information, material degradation signs, and safe disposal procedures. For devices intended for use by laypersons, circumstances requiring consultation with a healthcare professional should be noted.


In the realm of medical device regulations, proper labeling is non-negotiable. The EU MDR labeling requirements are designed to enhance patient safety, streamline traceability, and ensure that healthcare professionals and patients have access to essential information. Staying informed about these regulations and diligently following them is essential for manufacturers looking to market their medical devices in the European Union. Compliance may require significant effort and resources, but it's an investment in patient safety and market access.


Are you ready to ensure your medical devices meet EU MDR labeling requirements? Always consult with regulatory experts to navigate the complex landscape of EU MDR labeling successfully.


Our team of regulatory experts is here to guide you through the process, from understanding the intricacies of EU MDR labeling to implementing the necessary changes. Don't let compliance challenges hold you back from accessing the European market and prioritizing patient safety.


Compliance with EU MDR is not just about adhering to regulations; it's about delivering safe and effective medical devices to those who need them most. Contact us today to get started on your journey to EU MDR labeling compliance. Your success is our commitment.


Let us be your partner in achieving the EU MDR Labeling compliance !





תגובות


bottom of page